Protein detail
PRIO
Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)
Entry name PRIO | UniProt ID | EVMP confidence score 0.88 |
Supporting publications (n) 21 | Transmembrane count | Protein classification CD markersDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters |
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40Basic Information11
Protein Names
Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)
Protein Class (7)
CD markersDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters
Protein Function (5)
- Human disease related genes:Nervous system diseases:Neurodegenerative diseases
- CD markers
- Potential drug targets
- Transporters:Transporter channels and pores
- Disease related genes
Ensembl
Entrez Gene Symbol
Gene Synonym (6)
AltPrPCD230CJDGSSPRIPPRP
Gene Description
Prion protein
Chromosome
20
Position
4686350-4701590
Supporting publications (n)
21
EVMP confidence score
0.88
Fluorescence & Localization2
Tissue Specificskeletal muscleCell SpecificAlveolar cells type 1
Function & Pathway7
Protein Function (5)
- Human disease related genes:Nervous system diseases:Neurodegenerative diseases
- CD markers
- Potential drug targets
- Transporters:Transporter channels and pores
- Disease related genes
Cellular Component (18)
- GO:0005737 cytoplasm
- GO:0005741 mitochondrial outer membrane
- GO:0005783 endoplasmic reticulum
- GO:0005794 Golgi apparatus
- GO:0005829 cytosol
- GO:0005886 plasma membrane
- GO:0009897 external side of plasma membrane
- GO:0009986 cell surface
- GO:0014069 postsynaptic density
- GO:0016234 inclusion body
Page 1 of 2
Molecular Function (21)
- GO:0001540 amyloid-beta binding
- GO:0002020 protease binding
- GO:0005507 copper ion binding
- GO:0005515 protein binding
- GO:0005521 lamin binding
- GO:0005539 glycosaminoglycan binding
- GO:0008017 microtubule binding
- GO:0015631 tubulin binding
- GO:0019828 aspartic-type endopeptidase inhibitor activity
- GO:0031802 type 5 metabotropic glutamate receptor binding
Page 1 of 3
Biological Process (3)
KEGG (3)
Reactome (5)
Mediation Categories (6)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence70
Enzyme-Mediated Modification (2)
2 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| PRNP | CDK5 | Q00535 | S | 43 | phosphorylation | Sparser_ProtMapperPhosphoSitePhosphoSite_ProtMapperProtMapper | ProtMapper:19587281 |
| PRNP | CDK5R1 | Q15078 | S | 43 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:19587281ProtMapper:25572400 |
Ligand-Receptor Signaling (63)
63 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| receptor | receptor | GO_Intercell | No | Yes | No | Yes | Yes |
| receptor | receptor | OmniPath | No | Yes | No | Yes | Yes |
| extracellular | extracellular | DGIdb | No | No | No | Yes | Yes |
| extracellular | extracellular | DGIdb | No | No | No | Yes | Yes |
| extracellular | extracellular | OmniPath | No | No | No | Yes | Yes |
| extracellular | extracellular | OmniPath | No | No | No | Yes | Yes |
| intracellular | intracellular | ComPPI | No | No | No | Yes | Yes |
| intracellular | intracellular | ComPPI | No | No | No | Yes | Yes |
| intracellular | intracellular | GO_Intercell | No | No | No | Yes | Yes |
| intracellular | intracellular | UniProt_location | No | No | No | Yes | Yes |
Page 1 of 7Next
Regulatory Interaction Network (1)
1 record.
| Source Protein Symbol | Source UniProt ID | Target Protein Symbol | Target UniProt ID | Is Directed | Is Stimulation | Is Inhibition | Database | References |
|---|---|---|---|---|---|---|---|---|
| CDK5 | Q00535 | PRIO | P04156 | Yes | Yes | No | iPTMnetSIGNORProtMapperPhosphoSitePhosphoSite_ProtMapper | PhosphoSite:25572400SIGNOR:19587281PhosphoSite:24360565 |
Protein Complex Composition (3)
3 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| PRNP homo-oligomer complex | PRNP | P04156 | 2 | CORUMPDB | PDB:3nhdPDB:3md4PDB:3hesPDB:3md5PDB:7rl4PDB:3nhcPDB:6lniCORUM:2007PDB:3herPDB:7dwvPDB:3heqPDB:6uurPDB:3hj5PDB:4e1hPDB:7un5PDB:4e1iPDB:7rvjPDB:6pq5PDB:7umq | 16148934 |
| PRNP-ApolopoproteinE3 complex | APOEPRNP | P02649P04156 | 1:1 | Compleat | Compleat:HC2949 | 16764853 |
| PRNP-ApolopoproteinE3 complex | PRNPQ13791 | P04156Q13791 | 0:0 | CORUM | CORUM:1088 | 16764853 |
Isolation & Detection Technology (1)
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential UltracentrifugationUltrafiltration / Tangential Flow Filtration | Mass spectrometry | 1 | 37786918 |
Sequence, Structure & Domains14
Sequences
Length
253
Mass
27,661
Sequence
MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG
Alternative Products
Event=Alternative initiation; Named isoforms=2; Name=1; Synonyms=PrP; IsoId=P04156-1; Sequence=Displayed; Name=3; Synonyms=AltPrP; IsoId=F7VJQ1-1; Sequence=External
3D Structural Models
Turn
74..76; 114..117; 171..173; 193..195; 223..225; 228..230
Helix
144..153; 154..156; 166..168
Beta Strand
63..67; 70..73; 79..82; 92..95; 99..101; 109..112; 118..122; 125..127; 128..131; 133..135; 138..140; 141..143; 159..163; 178..181; 182..185; 189..192; 196..202; 205..210; 212..215
3D Structure
Electron microscopy (11); NMR spectroscopy (34); X-ray crystallography (25)
Domain & Motif Annotations
Compositional Bias
52..95; Gly residues
Repeat
51..59; 1; 60..67; 2; 68..75; 3; 76..83; 4; 84..91; 5
Domain (CC)
The normal, monomeric form, PRPN(C), has a mainly alpha-helical structure. Misfolding of this form produces a disease-associated, protease-resistant form, PRPN (Sc), accompanied by a large increase of the beta-sheet content and formation of amyloid fibrils. These fibrils consist of a cross-beta spine, formed by a steric zipper of superposed beta-strands. Disease mutations may favor intermolecular contacts via short beta strands, and may thereby trigger oligomerization. In addition, the heparan-sulfate proteoglycan, GPC1, promotes the association of PRPN (C) to lipid rafts and appears to facilitate the conversion to PRPN (Sc).; DOMAIN: Contains an N-terminal region composed of octamer repeats. At low copper concentrations, the sidechains of His residues from three or four repeats contribute to the binding of a single copper ion. Alternatively, a copper ion can be bound by interaction with the sidechain and backbone amide nitrogen of a single His residue. The observed copper binding stoichiometry suggests that two repeat regions cooperate to stabilize the binding of a single copper ion. At higher copper concentrations, each octamer can bind one copper ion by interactions with the His sidechain and Gly backbone atoms. A mixture of binding types may occur, especially in the case of octamer repeat expansion. Copper binding may stabilize the conformation of this region and may promote oligomerization.
Region
23..230; Interaction with GRB2, ERI3 and SYN1; 23..38; Interaction with ADGRG6; 26..108; Disordered; 51..91; 5 X 8 AA tandem repeats of P-H-G-G-G-W-G-Q
Protein Families
Prion family
Sequence Similarities
Belongs to the prion family.
Clinical Relevance7
Disease Involvement (2)
AmyloidosisDisease variant
Drug Targets
Literature-reported target
Drugs
Interaction Protein (9)
ENSG00000022267ENSG00000103152ENSG00000129195ENSG00000155760ENSG00000163823ENSG00000164251ENSG00000169252ENSG00000169403ENSG00000173846
Interaction Count
9
Interaction Dataset
intact_biogrid
Supporting Publications19
| PMID | Title | Abstract |
|---|---|---|
| 34623918 | Metabolic responsiveness to training depends on insulin sensitivity and protein content of exosomes in insulin-resistant males. | No abstract available |
| 34817906 | Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform. | No abstract available |
| 36398564 | Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles. | No abstract available |
| 37786918 | Rapid and in-depth proteomic profiling of small extracellular vesicles for ultralow samples. | No abstract available |
| 38321535 | Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles. | No abstract available |
| 39766158 | A Proteomic Examination of Plasma Extracellular Vesicles Across Colorectal Cancer Stages Uncovers Biological Insights That Potentially Improve Prognosis. | No abstract available |
| 39940641 | Disease-Associated Signatures Persist in Extracellular Vesicles from Reprogrammed Cells of Osteoarthritis Patients. | No abstract available |
| 40089067 | Metabolic Reprogramming Into a Glycolysis Phenotype Induced by Extracellular Vesicles Derived From Prostate Cancer Cells. | No abstract available |
| 41216884 | Extracellular Vesicles From Multiple Sclerosis White Matter Exhibit Synaptic, Mitochondrial, Complement and Ageing-Related Pathway Dysregulation. | No abstract available |
Page 2 of 2Previous